Guidant Wealth Advisors’s Cardinal Health CAH Stock Holding History

Guidant Wealth Advisors’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-13	Closed	–	–	230
2018 Q1	$0	Buy	+13	New	+$892	﹤0.01%	218

Other funds holding CAH

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AIG

American International Group New York $609M AUM 23.67% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Guidant Wealth Advisors's CAH Position: Q2 2018 in Review

Guidant Wealth Advisors sold out of Cardinal Health (CAH) in Q2 2018, closing a stake of 13 shares.

Guidant Wealth Advisors first reported a position in CAH in Q1 2018 and held it in 1 quarter. The position peaked at $0 in Q1 2018. 711 funds tracked by Wall St. Rank hold CAH as of Q2 2018.

Guidant Wealth Advisors reported no remaining Cardinal Health position as of Q2 2018 after selling out during the quarter.
Guidant Wealth Advisors sold 13 Cardinal Health shares in Q2 2018.
Guidant Wealth Advisors first reported a position in Cardinal Health in Q1 2018 and held it in 1 quarter.
Guidant Wealth Advisors's Cardinal Health position peaked at $0 in Q1 2018.
711 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2018.

Based on Guidant Wealth Advisors's 13F filing for Q2 2018, filed 11 Jul 2018.